RLAYRelay Therapeutics, Inc.

$18.17+179% 1Y

Is it growing?

Good

Revenue growing +24% year on year. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Revenue trend+24% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RLAY growing?

Relay Therapeutics, Inc.'s revenue has grown 122% a year over three years.

+122%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Years of annual history on file
7

Years of annual history on file · FY2019 to FY2025, as filed

Details›
Revenue FY2021
$3.0M
Revenue FY2022
$1.4M
Revenue FY2023
$26M
Revenue FY2024
$10M
Revenue FY2025
$15M

Annual income statements as filed with the SEC.

On our screens:Most shorted stocks